For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and HF hospitalization.

New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase Agreement Payment from RTW Extended Through 2025 MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Phar ...

New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase Agreement Payment from RTW Extended Through 2025 MONTREAL an ...

Milestone Pharmaceuticals Inc. is a strong buy under $2 with FDA approval for Cardamyst expected in 2026, offering unique ...

People reporting cold drinks or foods as triggers for their atrial fibrillation (Afib) were invited to a survey. Approximately half the cohort reported reducing their Afib episodes by avoiding ...

In fact, for half of the survey participants who identified cold ingestion as an Afib trigger, avoiding cold drinks and foods completely eliminated their episodes.

In a new survey of people with afib, most said they have ‘cold drink heart,’ meaning cold drinks sometimes lead to irregular or rapid heart rhythms.

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR.

It may be hard to separate cause from effect as people with AFib are more likely to develop gastrointestinal issues, but your story of severe cramps just before the onset of AFib is suggestive ...

Milestone is on track to initiate a Phase 3 trial evaluating etripamil in AFib-RVR in 2025. The protocol of a Phase 3, potentially registrational study has been finalized and study start-up has ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR.